Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial

Grange, J. D.; Roulot, D.; Pelletier, G.; Pariente, E. A.; Denis, J.; Ink, O.; Blanc, P.; Richardet, J. P.; Vinel, J. P.; Delisle, F.; Fischer, D.; Flahault, Antoine; Amiot, X.

doi:10.1016/S0168-8278(98)80061-5

Scientific article

English

Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial

ContributorsGrange, J. D.; Roulot, D.; Pelletier, G.; Pariente, E. A.; Denis, J.; Ink, O.; Blanc, P.; Richardet, J. P.; Vinel, J. P.; Delisle, F.; Fischer, D.; Flahault, Antoine; Amiot, X.

Published inJournal of hepatology, vol. 29, no. 3, p. 430-436

Publication date1998

Keywords

Adult
Aged
Anti-Infective Agents/adverse effects/*therapeutic use
Ascites/complications/*drug therapy/mortality
Double-Blind Method
Feces/microbiology
Female
France/epidemiology
Gram-Negative Bacterial Infections/complications/epidemiology/*prevention & control
Humans
Incidence
Liver Cirrhosis/*complications/mortality
Male
Middle Aged
Norfloxacin/adverse effects/*therapeutic use
Patient Compliance
Survival Rate

Affiliation entities

Not a UNIGE publication

Citation (ISO format)

GRANGE, J. D. et al. Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial. In: Journal of hepatology, 1998, vol. 29, n° 3, p. 430–436. doi: 10.1016/S0168-8278(98)80061-5

Article (Published version)

Identifiers

PID : unige:47154
DOI : 10.1016/S0168-8278(98)80061-5
PMID : 9764990

Journal ISSN0168-8278

627views

0downloads

Creation23/02/2015 14:34:57

First validation23/02/2015 14:34:57

Update14/03/2023 22:54:23

Status update14/03/2023 22:54:22

Last indexation30/10/2024 23:04:35

Archive ouverte UNIGE

Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial

Technical informations